In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they intend to reclassify cannabis like a Program III drug. This rescheduling will figure out that cannabis has genuine clinical functions and might help open up the door to research on other potential treatment method works by using. Weed pens and https://johne432uky9.blogunok.com/profile